Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Dow Jones Newswires compiled a roundup of private markets headlines and stories published on the last trading day. The package includes financing, IPO, acquisition, recall and partnership updates.
Retension Pharmaceuticals expects its shares to start trading on the Nasdaq Capital Market on Oct. 9 under ticker symbol RTSN.
Retension Pharmaceuticals priced its upsized initial public offering at $12.00 a share for 3,750,000 common shares. The company expects gross proceeds of $45.0 million before expenses and says trading should begin on Oct. 9 on Nasdaq under RTSN.